Epitope-Based Vaccines: The Next Generation of Promising Vaccines Against Bacterial Infection

Area of Science:

• Immunology
• Vaccinology
• Microbiology

Background:

• Antibiotic resistance is a growing global health threat, necessitating novel strategies for bacterial infection prevention.
• The World Health Organization (WHO) prioritizes reducing multidrug resistance through its One Health initiative.
• Epitopes are specific antigen regions that elicit targeted immune responses, forming the basis for advanced vaccine design.

Purpose of the Study:

• To review the advancements, challenges, and future directions of epitope-based vaccines against bacterial infections.
• To focus on the development and application of these vaccines against high-mortality, antibiotic-resistant pathogens.
• To provide insights into next-generation vaccination strategies for combating resistant bacterial infections.

Main Methods:

• Review of current literature on epitope-based vaccine development.
• Analysis of epitope discovery and selection workflows.
• Examination of challenges such as epitope escape and immunogenicity.

Main Results:

• Epitope-based vaccines can induce more efficient and specific immune responses compared to traditional vaccines.
• These vaccines offer potential advantages including minimal adverse reactions, improved efficacy, and optimized protection.
• Significant challenges remain, including epitope escape and achieving sufficient immunogenicity.

Conclusions:

• Epitope-based vaccines represent a promising next-generation approach to combatting bacterial infections, particularly those caused by antibiotic-resistant strains.
• Further research and development are crucial to overcome existing challenges and fully realize the potential of these vaccines.
• Targeting high-mortality pathogens like *Staphylococcus aureus* and *Klebsiella pneumoniae* with epitope-based vaccines is a key future direction.